RARE
Ultragenyx Pharm (RARE)
NASDAQ
$15.96+$0.04 (+0.22%)
Price as of Oct 22, 2026 7:56 PM EDT
  • $1.6B
    Market Cap
  • -51.96%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 36
Valuation
RARE
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 45
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
-45.44%
12-Month Momentum
-54.33%
3-Month Risk Adjusted Momentum
-92.42%
12-Month Risk Adjusted Momentum
-67.61%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 44
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6